• Pranav kumar
• vishal shrivastava
• Akhilesh Kumar Singhai

Nanotechnology, particularly through nanoparticles (NPs), has revolutionized modern medicine, offering new avenues for therapeutic strategies, diagnostics, and targeted drug delivery. NPs possess unique properties like size, shape, and surface charge, making them adaptable for various biomedical applications. In drug delivery, they enhance solubility and stability while reducing off-target effects. Functionalized NPs can precisely target diseased tissues, improving efficacy and minimizing side effects. Additionally, NPs are valuable in diagnostics, enabling sensitive detection of disease biomarkers through advanced imaging techniques like MRI and CT scans. In therapeutics, they play a role in gene therapy, immunotherapy, and regenerative medicine, allowing efficient gene delivery, immune modulation, and tissue regeneration. Despite their potential, challenges persist in clinical translation, including concerns about biocompatibility and scalability. Collaboration among researchers, clinicians, engineers, and regulatory agencies is crucial to optimize NP design and ensure safety. In conclusion, NPs signify a paradigm shift in medicine, promising advancements in treatment and diagnosis across a wide spectrum of diseases, ultimately improving patient outcomes and quality of life.

NANOPARTICLE, NANOMEDICINE, CANCER, MODERN MEDICINE.

"USE OF NANOPARTICLES IN MODERN MEDICINE", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.11, Issue 4, page no.h527-h542, April-2024, Available :http://www.jetir.org/papers/JETIR2404764.pdf

"USE OF NANOPARTICLES IN MODERN MEDICINE", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.11, Issue 4, page no. pph527-h542, April-2024, Available at : http://www.jetir.org/papers/JETIR2404764.pdf